Brennan A Scott, MD
Gastroenterology · Los Altos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Scott’s office at (650) 254-5200 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A66164 · Current
Licensed to practise in California · since 1998 · expires 2027-11-30 · New York Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$105,605
Medicare paid this office $105,605 for 470 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 161 | $36,507 | $227 |
| Biopsy of large bowel using a flexible endoscope | 147 | $15,252 | $104 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 44 | $8,963 | $204 |
| Long return visit (40+ min) | 30 | $6,064 | $168 |
| Short return visit (20+ min) | 66 | $5,551 | $79 |
See all 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 161 | $36,507 | $227 |
| Biopsy of large bowel using a flexible endoscope | 147 | $15,252 | $104 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 44 | $8,963 | $204 |
| Long return visit (40+ min) | 30 | $6,064 | $168 |
| Short return visit (20+ min) | 66 | $5,551 | $79 |
| Return visit (30+ min) | 38 | $4,246 | $96 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 49 | $4,083 | $83 |
| New patient visit (45+ min) | 22 | $3,033 | $138 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,269 | $206 |
| New patient visit (30+ min) | 17 | $1,619 | $95 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 300 | $1,326 | $4 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $863 | $66 |
| Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | 14 | $657 | $47 |
Procedures Medicare counted
| Colonoscopy | 192 | More than 93% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 78 | More than 72% of doctors who do this |
Who their Medicare patients are
470 Original Medicare patients in 2024. Average age 75 · Women 45% · Also on Medicaid 4% · Health risk score 0.77. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 54% · Coronary heart disease 20% · Cancer 17% · Diabetes 16% · Chronic kidney disease 14% · Atrial fibrillation 13% · Depression 8% · Heart failure 4% · COPD 4% · Stroke 4%.
The office billed $1,086,085, Medicare allowed $132,259 and paid $105,605; for 1,022 services of 35 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 470 | 1,022 | 75 | 0.77 | $1,086,085 | $105,605 |
| 2023 | 465 | 1,014 | 74 | 0.75 | $1,021,549 | $110,907 |
| 2022 | 454 | 1,022 | 74 | 0.74 | $989,246 | $106,270 |
| 2021 | 473 | 1,008 | 75 | 0.78 | $889,706 | $107,476 |
| 2020 | 398 | 845 | 75 | 0.79 | $768,533 | $85,630 |
| 2019 | 432 | 926 | 74 | 0.89 | $911,670 | $92,615 |
| 2018 | 436 | 1,063 | 74 | 0.85 | $964,751 | $98,683 |
| 2017 | 447 | 1,172 | 74 | 0.94 | $921,372 | $104,674 |
| 2016 | 431 | 706 | 74 | 1.02 | $781,323 | $99,524 |
| 2015 | 394 | 633 | 74 | 0.93 | $698,554 | $102,657 |
| 2014 | 323 | 523 | 73 | 0.91 | $562,327 | $77,363 |
| 2013 | 290 | 520 | 73 | 0.96 | $533,335 | $79,607 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 129 | $29,371 | $228 |
| Biopsy of large bowel using a flexible endoscope | 163 | $19,723 | $121 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 56 | $11,812 | $211 |
| Return visit (30+ min) | 43 | $5,984 | $122 |
| Removal of large bowel tissue using a flexible endoscope | 17 | $5,452 | $321 |
| Long return visit (40+ min) | 30 | $5,056 | $158 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 20 | $4,221 | $211 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 52 | $4,073 | $75 |
| Short return visit (20+ min) | 38 | $3,614 | $86 |
| New patient visit (30+ min) | 26 | $2,597 | $100 |
| New patient visit (45+ min) | 20 | $2,550 | $127 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 283 | $1,418 | $5 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 12 | $1,278 | $107 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $1,164 | $65 |
2022: 15 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 132 | $29,882 | $226 |
| Biopsy of large bowel using a flexible endoscope | 151 | $16,495 | $109 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 44 | $9,383 | $213 |
| Long return visit (40+ min) | 45 | $7,426 | $155 |
| Return visit (30+ min) | 38 | $4,881 | $119 |
| Removal of external hemorrhoids by rubber banding | 11 | $4,632 | $290 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 52 | $4,607 | $87 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 18 | $3,730 | $207 |
| New patient visit (45+ min) | 26 | $3,370 | $130 |
| Removal of large bowel tissue using a flexible endoscope | 11 | $3,183 | $289 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 30 | $2,286 | $76 |
| Short return visit (20+ min) | 24 | $1,841 | $77 |
| New patient visit (30+ min) | 16 | $1,533 | $96 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 291 | $1,439 | $5 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 44 | $1,003 | $22 |
2021: 15 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 102 | $23,290 | $228 |
| Biopsy of large bowel using a flexible endoscope | 130 | $15,259 | $117 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 49 | $10,599 | $216 |
| Long return visit (40+ min) | 52 | $8,615 | $160 |
| Return visit (30+ min) | 54 | $6,384 | $114 |
| New patient visit (45+ min) | 43 | $6,111 | $142 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 57 | $4,820 | $85 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 19 | $4,116 | $217 |
| New patient visit (30+ min) | 32 | $3,305 | $103 |
| New patient visit (60+ min) | 13 | $2,674 | $206 |
| Short return visit (20+ min) | 34 | $2,444 | $70 |
| Diagnostic exam of large bowel using a flexible endoscope | 11 | $1,728 | $157 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 273 | $1,422 | $5 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $1,386 | $77 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 26 | $535 | $21 |
2020: 14 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 84 | $19,879 | $237 |
| Biopsy of large bowel using a flexible endoscope | 133 | $17,921 | $135 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 38 | $8,199 | $216 |
| Return visit (30+ min) | 54 | $5,627 | $94 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 18 | $3,949 | $219 |
| New patient visit (30+ min) | 37 | $3,713 | $100 |
| New patient visit (45+ min) | 22 | $3,291 | $150 |
| Long return visit (40+ min) | 22 | $2,849 | $129 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 36 | $2,849 | $79 |
| Short return visit (20+ min) | 37 | $2,335 | $60 |
| Diagnostic exam of large bowel using a flexible endoscope | 11 | $1,775 | $161 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 240 | $1,263 | $5 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,011 | $59 |
| New patient visit (15+ min) | 11 | $810 | $74 |
2019: 15 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 100 | $22,894 | $227 |
| Biopsy of large bowel using a flexible endoscope | 158 | $20,274 | $128 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 25 | $5,387 | $215 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 63 | $5,283 | $83 |
| Return visit (30+ min) | 54 | $5,057 | $90 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 21 | $4,415 | $210 |
| Short return visit (20+ min) | 46 | $3,587 | $61 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $3,156 | $175 |
| New patient visit (45+ min) | 16 | $2,243 | $140 |
| New patient visit (30+ min) | 22 | $1,977 | $90 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 14 | $1,756 | $110 |
| Long return visit (40+ min) | 11 | $1,531 | $139 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 250 | $1,283 | $5 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $861 | $78 |
| Injection beneath lining of large bowel using a flexible endoscope | 21 | $322 | $15 |
2018: 16 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 119 | $27,569 | $232 |
| Biopsy of large bowel using a flexible endoscope | 167 | $18,504 | $111 |
| Return visit (30+ min) | 68 | $6,292 | $91 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 62 | $4,690 | $74 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 21 | $4,358 | $208 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 21 | $4,354 | $207 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $3,630 | $158 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $3,259 | $233 |
| New patient visit (45+ min) | 22 | $3,119 | $142 |
| Long return visit (40+ min) | 16 | $2,047 | $128 |
| Short return visit (20+ min) | 25 | $1,832 | $65 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 266 | $1,310 | $5 |
| New patient visit (30+ min) | 14 | $1,205 | $86 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 77 | $1,044 | $12 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $1,041 | $74 |
| Injection beneath lining of large bowel using a flexible endoscope | 26 | $399 | $15 |
2017: 18 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 97 | $22,563 | $233 |
| Biopsy of large bowel using a flexible endoscope | 157 | $18,038 | $115 |
| Return visit (30+ min) | 55 | $5,606 | $95 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 73 | $5,225 | $68 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 24 | $5,097 | $212 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 24 | $5,090 | $212 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 21 | $4,269 | $194 |
| New patient visit (45+ min) | 28 | $3,885 | $139 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $3,748 | $220 |
| Long return visit (40+ min) | 24 | $3,012 | $125 |
| Short return visit (20+ min) | 36 | $2,432 | $59 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 148 | $1,922 | $11 |
| Diagnostic exam of large bowel using a flexible endoscope | 14 | $1,801 | $129 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | $1,765 | $88 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 11 | $1,521 | $117 |
| New patient visit (30+ min) | 11 | $1,014 | $92 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 217 | $975 | $4 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 39 | $403 | $10 |
2016: 15 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 91 | $21,491 | $234 |
| Biopsy of large bowel using a flexible endoscope | 132 | $17,245 | $131 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 28 | $5,979 | $214 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 25 | $5,438 | $218 |
| Return visit (30+ min) | 55 | $5,437 | $94 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 51 | $4,331 | $83 |
| New patient visit (45+ min) | 30 | $4,173 | $139 |
| Long return visit (40+ min) | 19 | $2,602 | $124 |
| Short return visit (20+ min) | 38 | $2,589 | $62 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $2,322 | $211 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $2,278 | $207 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $2,088 | $174 |
| New patient visit (30+ min) | 16 | $1,611 | $101 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | $1,417 | $71 |
| Injection beneath lining of large bowel using a flexible endoscope | 17 | $265 | $16 |
2015: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 72 | $20,398 | $283 |
| Biopsy of large bowel using a flexible endoscope | 107 | $18,520 | $173 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 34 | $8,265 | $243 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 26 | $6,281 | $242 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 57 | $4,564 | $80 |
| Return visit (30+ min) | 47 | $4,539 | $93 |
| New patient visit (45+ min) | 29 | $4,465 | $154 |
| Short return visit (20+ min) | 37 | $2,916 | $69 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,825 | $107 |
| New patient visit (30+ min) | 18 | $1,737 | $97 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 11 | $1,711 | $132 |
| Injection beneath lining of large bowel using a flexible endoscope | 17 | $460 | $27 |
2014: 9 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 62 | $16,245 | $262 |
| Biopsy of large bowel using a flexible endoscope | 100 | $16,106 | $161 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 27 | $6,335 | $235 |
| New patient visit (45+ min) | 27 | $3,948 | $146 |
| Return visit (30+ min) | 37 | $3,613 | $90 |
| Short return visit (20+ min) | 42 | $3,378 | $64 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 13 | $3,131 | $241 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 38 | $2,960 | $76 |
| New patient visit (30+ min) | 30 | $2,937 | $98 |
2013: 10 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 46 | $12,297 | $267 |
| Biopsy of large bowel using a flexible endoscope | 74 | $11,921 | $161 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 26 | $6,138 | $236 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 20 | $4,672 | $234 |
| New patient visit (45+ min) | 32 | $4,374 | $137 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 34 | $3,427 | $98 |
| Short return visit (20+ min) | 44 | $3,178 | $59 |
| Return visit (30+ min) | 27 | $3,017 | $97 |
| New patient visit (30+ min) | 24 | $1,972 | $82 |
| New patient visit (15+ min) | 12 | $849 | $71 |
Drugs they prescribed that Part D paid
$330,706
Pharmacies billed $330,706 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
376 generic and 176 brand-name prescriptions · $330,706 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vemlidy | 18 | $42,028 | $2,335 |
| Creon | 11 | $40,510 | $3,683 |
| Sod Sulf-Potass Sulf-Mag Sulf | 232 | $15,171 | $65 |
| Linzess | 12 | $9,454 | $788 |
| Mesalamine | 26 | $7,970 | $307 |
See all 10 drugs
| Vemlidy | 18 | $42,028 | $2,335 |
| Creon | 11 | $40,510 | $3,683 |
| Sod Sulf-Potass Sulf-Mag Sulf | 232 | $15,171 | $65 |
| Linzess | 12 | $9,454 | $788 |
| Mesalamine | 26 | $7,970 | $307 |
| Omeprazole | 72 | $1,231 | $17 |
| Peg 3350-Electrolyte | 41 | $823 | $20 |
| Pantoprazole | 19 | $361 | $19 |
| Famotidine | 12 | $321 | $27 |
| Entecavir | 12 | $210 | $18 |
Year by year
| 2024 | 552 | 344 | None | 32% | $330,706 |
| 2023 | 546 | 355 | 0% (0) | 36% | $359,763 |
| 2022 | 445 | 245 | 0% (0) | 48% | $158,129 |
| 2021 | 569 | 335 | 0% (0) | 54% | $132,496 |
| 2020 | 524 | 299 | None | 48% | $143,816 |
| 2019 | 541 | 295 | 0% (0) | 48% | $138,797 |
| 2018 | 539 | 308 | 0% (0) | 39% | $57,431 |
| 2017 | 513 | 288 | 0% (0) | None | $57,468 |
| 2016 | 450 | 244 | None | 42% | $46,575 |
| 2015 | 463 | 248 | 0% (0) | 47% | $211,422 |
| 2014 | 363 | 199 | None | 59% | $163,823 |
| 2013 | 294 | 159 | 0% (0) | 51% | $45,890 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Creon | 19 | $57,446 | $3,023 |
| Vemlidy | 17 | $40,105 | $2,359 |
| Mesalamine | 26 | $16,873 | $649 |
| Sod Sulf-Potass Sulf-Mag Sulf | 209 | $16,615 | $79 |
| Ursodiol | 11 | $2,911 | $265 |
| Suprep | 13 | $1,490 | $115 |
| Omeprazole | 63 | $1,216 | $19 |
| Peg 3350-Electrolyte | 56 | $1,183 | $21 |
| Entecavir | 15 | $679 | $45 |
| Famotidine | 15 | $534 | $36 |
| Gavilyte-G | 14 | $243 | $17 |
| Pantoprazole | 16 | $202 | $13 |
2022: 9 drugs
| Vemlidy | 24 | $33,855 | $1,411 |
| Suprep | 146 | $16,813 | $115 |
| Mesalamine | 17 | $12,525 | $737 |
| Omeprazole | 72 | $1,708 | $24 |
| Entecavir | 18 | $1,102 | $61 |
| Pantoprazole | 22 | $920 | $42 |
| Azathioprine | 11 | $743 | $68 |
| Peg 3350-Electrolyte | 24 | $389 | $16 |
| Famotidine | 15 | $357 | $24 |
2021: 12 drugs
| Vemlidy | 23 | $30,575 | $1,329 |
| Suprep | 201 | $22,338 | $111 |
| Mesalamine | 17 | $11,871 | $698 |
| Ursodiol | 14 | $3,391 | $242 |
| Clenpiq | 21 | $3,348 | $159 |
| Omeprazole | 77 | $1,777 | $23 |
| Pantoprazole | 23 | $1,085 | $47 |
| Azathioprine | 14 | $926 | $66 |
| Tenofovir Disoproxil | 12 | $900 | $75 |
| Famotidine | 23 | $616 | $27 |
| Entecavir | 11 | $465 | $42 |
| Peg 3350-Electrolyte | 28 | $410 | $15 |
2020: 10 drugs
| Suprep | 192 | $20,206 | $105 |
| Delzicol | 13 | $3,187 | $245 |
| Omeprazole | 77 | $1,928 | $25 |
| Tenofovir Disoproxil | 28 | $1,458 | $52 |
| Entecavir | 14 | $1,218 | $87 |
| Azathioprine | 19 | $1,054 | $55 |
| Pantoprazole | 16 | $569 | $36 |
| Peg 3350-Electrolyte | 31 | $456 | $15 |
| Famotidine | 12 | $281 | $23 |
| Gavilyte-N | 11 | $152 | $14 |
2019: 10 drugs
| Omeprazole-Sodium Bicarbonate | 11 | $18,299 | $1,664 |
| Suprep | 178 | $17,801 | $100 |
| Delzicol | 11 | $2,535 | $230 |
| Omeprazole | 78 | $1,868 | $24 |
| Tenofovir Disoproxil | 20 | $1,124 | $56 |
| Pantoprazole | 29 | $713 | $25 |
| Azathioprine | 22 | $546 | $25 |
| Peg 3350-Electrolyte | 30 | $520 | $17 |
| Gavilyte-N | 12 | $162 | $14 |
| Famotidine | 11 | $117 | $11 |
2018: 11 drugs
| Linzess | 12 | $6,920 | $577 |
| Suprep | 59 | $5,573 | $94 |
| Delzicol | 13 | $2,737 | $211 |
| Omeprazole | 99 | $1,867 | $19 |
| Peg 3350-Electrolyte | 105 | $1,769 | $17 |
| Tenofovir Disoproxil | 11 | $993 | $90 |
| Gavilyte-N | 55 | $902 | $16 |
| Methotrexate | 13 | $761 | $59 |
| Pantoprazole | 20 | $622 | $31 |
| Peg 3350-Electrolyte | 21 | $201 | $10 |
| Tamsulosin | 13 | $156 | $12 |
2017: 12 drugs
| Viread | 14 | $14,799 | $1,057 |
| Balsalazide Disodium | 12 | $3,639 | $303 |
| Delzicol | 13 | $2,556 | $197 |
| Mercaptopurine | 13 | $2,246 | $173 |
| Peg 3350-Electrolyte | 136 | $1,899 | $14 |
| Omeprazole | 71 | $1,503 | $21 |
| Esomeprazole Magnesium | 14 | $1,290 | $92 |
| Gavilyte-N | 58 | $974 | $17 |
| Gavilyte-C | 18 | $187 | $10 |
| Pantoprazole | 15 | $186 | $12 |
| Tamsulosin | 13 | $161 | $12 |
| Peg 3350-Electrolyte | 12 | $110 | $9 |
2016: 11 drugs
| Viread | 16 | $21,599 | $1,350 |
| Delzicol | 13 | $2,376 | $183 |
| Esomeprazole Magnesium | 13 | $2,207 | $170 |
| Peg 3350-Electrolyte | 126 | $1,932 | $15 |
| Omeprazole | 65 | $1,548 | $24 |
| Balsalazide Disodium | 12 | $1,107 | $92 |
| Gavilyte-N | 51 | $885 | $17 |
| Pantoprazole | 17 | $253 | $15 |
| Lansoprazole | 11 | $184 | $17 |
| Tamsulosin | 12 | $166 | $14 |
| Propranolol | 11 | $81 | $7 |
2015: 11 drugs
| Viread | 24 | $27,847 | $1,160 |
| Nexium | 15 | $4,629 | $309 |
| Delzicol | 14 | $2,370 | $169 |
| Moviprep | 22 | $1,760 | $80 |
| Peg 3350-Electrolyte | 102 | $1,717 | $17 |
| Lansoprazole | 22 | $1,612 | $73 |
| Balsalazide Disodium | 11 | $1,530 | $139 |
| Gavilyte-N | 53 | $1,024 | $19 |
| Omeprazole | 53 | $838 | $16 |
| Pantoprazole | 18 | $285 | $16 |
| Trilyte With Flavor Packets | 14 | $273 | $20 |
2014: 11 drugs
| Viread | 14 | $17,190 | $1,228 |
| Lialda | 12 | $9,758 | $813 |
| Nexium | 21 | $8,132 | $387 |
| Delzicol | 12 | $1,735 | $145 |
| Balsalazide Disodium | 12 | $1,670 | $139 |
| Peg-3350 | 98 | $1,655 | $17 |
| Lansoprazole | 17 | $1,625 | $96 |
| Moviprep | 12 | $949 | $79 |
| Omeprazole | 27 | $647 | $24 |
| Gavilyte-N | 31 | $546 | $18 |
| Pantoprazole | 23 | $288 | $13 |
2013: 9 drugs
| Budesonide Ec | 14 | $13,515 | $965 |
| Carafate | 16 | $6,624 | $414 |
| Lansoprazole | 31 | $2,885 | $93 |
| Moviprep | 20 | $1,411 | $71 |
| Peg-3350 With Flavor Packs | 63 | $1,181 | $19 |
| Balsalazide Disodium | 12 | $1,097 | $91 |
| Omeprazole | 37 | $772 | $21 |
| Gavilyte-N | 21 | $371 | $18 |
| Trilyte With Flavor Packets | 16 | $306 | $19 |
Money from drug and device companies
$842 in 2025
| 2025 | 4 | 24 | None | $842 |
| 2023 | 1 | 1 | None | $150 |
| 2022 | 2 | 6 | None | $239 |
| 2019 | 2 | 3 | None | $338 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Biotech | Tremfya | $434 | 12 payments
|
| Lilly USA | Omvoh | $148 | 5 payments
|
| Boston Scientific | Apollo Revise System | $143 | 2 payments
|
| Abbvie | Rinvoq | $117 | 5 payments
|
See all 24 published payments
| Janssen Biotech | Meals · 2025-10-29 | Tremfya | $37 |
| Janssen Biotech | Meals · 2025-10-20 | Tremfya | $16 |
| Abbvie | Meals · 2025-10-18 | Rinvoq | $27 |
| Janssen Biotech | Meals · 2025-09-23 | Tremfya | $37 |
| Lilly USA | Meals · 2025-09-10 | Omvoh | $11 |
| Janssen Biotech | Meals · 2025-09-09 | Tremfya | $32 |
| Abbvie | Meals · 2025-09-05 | Linzess | $31 |
| Janssen Biotech | Meals · 2025-08-27 | Tremfya | $30 |
| Janssen Biotech | Meals · 2025-08-13 | Tremfya | $22 |
| Janssen Biotech | Meals · 2025-07-29 | Tremfya | $22 |
| Boston Scientific | Meals · 2025-07-17 | Orcapod | $43 |
| Lilly USA | Meals · 2025-07-14 | Omvoh | $35 |
| Abbvie | Meals · 2025-07-08 | Rinvoq | $16 |
| Abbvie | Meals · 2025-07-02 | Linzess | $25 |
| Janssen Biotech | Meals · 2025-06-17 | Tremfya | $41 |
| Abbvie | Meals · 2025-06-12 | Rinvoq | $18 |
| Lilly USA | Meals · 2025-05-28 | Omvoh | $32 |
| Janssen Biotech | Meals · 2025-05-21 | Tremfya | $25 |
| Janssen Biotech | Meals · 2025-05-15 | Tremfya | $130 |
| Lilly USA | Meals · 2025-04-28 | Omvoh | $35 |
| Janssen Biotech | Meals · 2025-04-08 | Tremfya | $23 |
| Lilly USA | Meals · 2025-04-01 | Omvoh | $35 |
| Janssen Biotech | Meals · 2025-03-12 | Tremfya | $20 |
| Boston Scientific | Meals · 2025-03-12 | Apollo Revise System | $100 |
See earlier years (2023, 2022, 2019)
2023: $150
| E.R. Squibb & Sons L.L.C. | Zeposia | $150 | 1 payment
|
2022: $239
| Abbvie | Skyrizi | $155 | 5 payments
|
| Boston Scientific | General - Biopsy | $83 | 1 payment
|
2019: $338
| Boston Scientific | General Biliary Devices | $248 | 2 payments
|
| AbbVie | None | $91 | 1 payment
|
Professional record
- NPI
- 1295809424
- Licence
- CA A66164California A66164: Current · expires 2027-11-30
- Trained
- New York University Medical College - Nlg, 1997
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-11-20
- NPI last updated
- 2020-05-14
- NPI record certified
- 2020-05-14
This is when the NPI record was last certified, not a medical board exam.